Headline News

High cardiorespiratory fitness corresponded with better cognitive function and a decreased risk for dementia, according to findings published in the British Journal of Sports Medicine.

Cognitive behavioral therapy delivered via telehealth using remote video reduced suicide attempts and suicidal ideation among high-risk adults, according to the results of a randomized clinical trial.

Optometry Giving Sight has named Donna J. Mikulecky, CPA, as the organization’s next executive director, replacing retiring Lois Schoenbrun, FAAO, according to a press release.

NEW YORK — In this Healio Video Perspective from OSN New York, William B. Trattler, MD, of the Center for Excellence in Eye Care in Miami, discusses how the EVO ICL may be beneficial for patients with keratoconus and myopia.

Treatment with Paxlovid significantly reduced the duration and severity of SARS-CoV-2 infection among high-risk patients while also reducing health care utilization and severe outcomes, according to a study.

SAN DIEGO — Increasing diversity and addressing gender and racial gaps among nephrology fellows requires immediate action, researchers said at ASN Kidney Week.

The FDA has approved Bimzelx for the treatment of moderate to severe hidradenitis suppurativa in adults, UCB announced in a press release.

DALLAS — In this video from the American Association of Hip and Knee Surgeons Annual Meeting, Robert A. Burnett, MD, discussed results that showed repeat mesh glue dressing exposure yielded a fivefold increased risk of allergic dermatitis.

BOSTON — Consensus criteria for anaphylaxis diagnosis are moving toward more objective assessments of symptoms, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

A phase 2 clinical trial of dalzanemdor in those with cognitive impairment associated with Huntington’s disease failed to meet its primary and secondary endpoints, causing the manufacturer to halt development of the investigational therapy.